Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8105841rdf:typepubmed:Citationlld:pubmed
pubmed-article:8105841lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:8105841lifeskim:mentionsumls-concept:C1527390lld:lifeskim
pubmed-article:8105841lifeskim:mentionsumls-concept:C0069515lld:lifeskim
pubmed-article:8105841lifeskim:mentionsumls-concept:C1704824lld:lifeskim
pubmed-article:8105841lifeskim:mentionsumls-concept:C2000948lld:lifeskim
pubmed-article:8105841lifeskim:mentionsumls-concept:C2000949lld:lifeskim
pubmed-article:8105841pubmed:issue11lld:pubmed
pubmed-article:8105841pubmed:dateCreated1993-12-9lld:pubmed
pubmed-article:8105841pubmed:abstractTextNormal and neoplastic human intracranial tissues were examined by immunohistochemistry for c-erbB-2/HER-2 protein expression. Positive staining was observed in 1/41 gliomas, 1/2 medulloblastomas, 1/1 germinoma, 11/16 meningiomas, 1/3 anaplastic meningiomas and 11/19 metastatic brain carcinomas. No positive staining was observed in normal intracranial tissues. Thus, the expression of the c-erbB-2/HER-2 protein is limited to intracranial tumour tissues, principally meningiomas and metastatic carcinomas to the brain.lld:pubmed
pubmed-article:8105841pubmed:languageenglld:pubmed
pubmed-article:8105841pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8105841pubmed:citationSubsetIMlld:pubmed
pubmed-article:8105841pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8105841pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8105841pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8105841pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8105841pubmed:statusMEDLINElld:pubmed
pubmed-article:8105841pubmed:issn0959-8049lld:pubmed
pubmed-article:8105841pubmed:authorpubmed-author:DalenAAlld:pubmed
pubmed-article:8105841pubmed:authorpubmed-author:UnsgaardGGlld:pubmed
pubmed-article:8105841pubmed:authorpubmed-author:HelsethEElld:pubmed
pubmed-article:8105841pubmed:authorpubmed-author:TorkS CSClld:pubmed
pubmed-article:8105841pubmed:issnTypePrintlld:pubmed
pubmed-article:8105841pubmed:volume29Alld:pubmed
pubmed-article:8105841pubmed:ownerNLMlld:pubmed
pubmed-article:8105841pubmed:authorsCompleteYlld:pubmed
pubmed-article:8105841pubmed:pagination1604-6lld:pubmed
pubmed-article:8105841pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:8105841pubmed:meshHeadingpubmed-meshheading:8105841-...lld:pubmed
pubmed-article:8105841pubmed:meshHeadingpubmed-meshheading:8105841-...lld:pubmed
pubmed-article:8105841pubmed:meshHeadingpubmed-meshheading:8105841-...lld:pubmed
pubmed-article:8105841pubmed:meshHeadingpubmed-meshheading:8105841-...lld:pubmed
pubmed-article:8105841pubmed:meshHeadingpubmed-meshheading:8105841-...lld:pubmed
pubmed-article:8105841pubmed:meshHeadingpubmed-meshheading:8105841-...lld:pubmed
pubmed-article:8105841pubmed:meshHeadingpubmed-meshheading:8105841-...lld:pubmed
pubmed-article:8105841pubmed:meshHeadingpubmed-meshheading:8105841-...lld:pubmed
pubmed-article:8105841pubmed:meshHeadingpubmed-meshheading:8105841-...lld:pubmed
pubmed-article:8105841pubmed:meshHeadingpubmed-meshheading:8105841-...lld:pubmed
pubmed-article:8105841pubmed:meshHeadingpubmed-meshheading:8105841-...lld:pubmed
pubmed-article:8105841pubmed:meshHeadingpubmed-meshheading:8105841-...lld:pubmed
pubmed-article:8105841pubmed:meshHeadingpubmed-meshheading:8105841-...lld:pubmed
pubmed-article:8105841pubmed:year1993lld:pubmed
pubmed-article:8105841pubmed:articleTitleC-erbB-2/HER-2 protein in human intracranial tumours.lld:pubmed
pubmed-article:8105841pubmed:affiliationInstitute of Cancer Research, University of Trondheim, Norway.lld:pubmed
pubmed-article:8105841pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8105841pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed